Investors / filer profile

Manning Paul B

active in 4 companies · 3 of 3 positions beat the S&P ~6mo later

Pro
Bought: Pro
Sold: 18
Filings: 4
Companies: 2026-06-16
Last filed

EDGAR · CIK 0001494695 ↗

Track record

How each disclosed position did against the S&P ~6 months later

The outcome curve and every position's resultPro →

+48.0%

median move per position

+12.4%

S&P 500 median, same spans

3 of 3

beat the S&P ~6mo later

Disclosed positions

Estimated from their latest filings — positions may have changed since

Estimated positions from their latest filingsPro →

Activity

Open-market buy & sell volume

BuySell

Total +$22.57M bought · −$31.74M sold

All filings on record

Every Form 4 transaction we track for this filer


LQDALiquidia Corp	Grant — · 5,882 sh	2026-06-16	—
LQDALiquidia Corp	Sell $812.3K · 12,610 sh	2026-06-04	—
LQDALiquidia Corp	Sell $4.36M · 68,265 sh	2026-06-04	—
LQDALiquidia Corp	Sell $1.20M · 19,125 sh	2026-06-04	—
LQDALiquidia Corp	Sell $5.69M · 88,487 sh	2026-06-04	—
LQDALiquidia Corp	Sell $726.8K · 11,513 sh	2026-06-04	—
CADLCandel Therapeutics, Inc.	Buy $3.00M · 550,458 sh	2026-02-23	—
LQDALiquidia Corp	Other $2.35M · 55,116 sh	2026-02-11	—
LQDALiquidia Corp	Other $2.35M · 55,116 sh	2026-02-11	—
VRCAVerrica Pharmaceuticals Inc.	Buy $11.67M · 2,750,762 sh	2025-11-25	—

LQDAGrant

2026-06-16 · Liquidia Corp

5,882

—

LQDASell

2026-06-04 · Liquidia Corp

$812.3K

—

LQDASell

2026-06-04 · Liquidia Corp

$4.36M

—

LQDASell

2026-06-04 · Liquidia Corp

$1.20M

—

LQDASell

2026-06-04 · Liquidia Corp

$5.69M

—

LQDASell

2026-06-04 · Liquidia Corp

$726.8K

—

CADLBuy

2026-02-23 · Candel Therapeutics, Inc.

$3.00M

—

LQDAOther

2026-02-11 · Liquidia Corp

$2.35M

—

LQDAOther

2026-02-11 · Liquidia Corp

$2.35M

—

VRCABuy

2025-11-25 · Verrica Pharmaceuticals Inc.

$11.67M

—

Newest 10 of 18 filingsEvery Form 4 on record, with outcomesPro →

Outcomes measure each position — the first buy in a stock and every buy within 182 days — against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.